ArticleBMC cancer2024

Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.